Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
Scientists hone tools to measure aging and rejuvenation interventions
Aging is malleable, at least in animal models. But to prove the efficacy of interventions aimed at extending healthspan and to test life-extending approaches in humans, longevity researchers first need to agree on the best measuring tools. With the power of ’omics, AI and large biobanks, improved biomarkers may be forthcoming. Companies and academic researchers are rallying forces, but how far have they gotten?
At the end of August, Copenhagen will welcome the who’s who in longevity research for the tenth Aging Research and Drug Discovery Meeting. Top of the agenda are interventions aimed at slowing or even reversing the aging process. But if the aim is to persuade the US Food and Drug Administration and other regulators to approve drugs, diets or supplements, the field needs to agree on the best biomarkers or tools to measure the changes that best characterize aging in humans.
